Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Mise à jour : Il y a 4 ans
Référence : NCT01134055

Femme et Homme

Extrait

The purpose of this study is to determine the safety and efficacy of different dosage regimens of pazopanib eye drops for the treatment of neovascular age-related macular degeneration.


Critère d'inclusion

  • Macular degeneration


Liens